A rapid response jab is on the way.
Photo: SMI

The new speed of vaccine production.

NEW EBOLA VACCINE

The world’s first clinical trials of a vaccine developed specifically for the new ‘Bundibugyo strain’ of Ebolavirus are underway, as scientists look to fast-track the product into arms.

Researchers at the University of Oxford have launched a Phase 1 trial of the ChAdOx1 BDBV vaccine, which has “been designed to target the Bundibugyo strain” of the ‘virus’.

Around 50 healthy adult volunteers will take part in the initial study, the poor souls, with scientists “assessing the vaccine’s ability to generate an immune response”.

The development comes in response to renewed fearmongering over Bundibugyo Ebolavirus ‘outbreaks’, including recent cases in the Democratic Republic of the Congo.

But Ethan – I thought they already have an Ebola vaccine?

Well, they do, but you know the narrative: New ‘strains’ arrive that ‘outperform the ability of current vaccines to keep pace’. Thie is known as the ‘Ebolavirus family’.

Existing vaccines were developed to ‘protect against Zaire strain’ of Ebolavirus, but they won’t provide protection against the ‘Bundibugyo strain’ because of ‘genetic differences’.

There has been an unusually rapid international research effort for this new vaccine.

The Coalition for Epidemic Preparedness Innovations (CEPI) has accelerated the development of three Bundibugyo-specific vaccine candidates simultaneously – backing a range of technologies in the hope that at least one will prove ‘safe and effective’.

One candidate, from Oxford, uses the ChAdOx1 platform – a non-replicating chimpanzee adenovirus vector that delivers ‘genetic instructions’ for a Bundibugyo virus protein.

This allows the immune system to, according to the university, “recognise and respond to the virus without exposing volunteers to the disease itself”.

Alongside the Oxford programme, additional vaccine candidates using mRNA and other ‘viral-vector technologies’ are also progressing through pre-clinical and early development.

The accelerated programme reflects the first implementation of ‘lessons’ learned during the COVID-19 ‘pandemic’, when vaccine platforms, manufacturing partnerships, and international funding mechanisms were developed at unprecedented speed.

Researchers emphasise that while development is being fast-tracked, the vaccines must still pass through ‘clinical testing’ before they can be approved for widespread use.

Like anyone would have confidence in that after the total sham trials COVIDS jabs went through, as we have covered here on the website extensively.

In parallel with vaccines, scientists have also begun evaluating potential antiviral treatment.

A clinical trial of the experimental oral antiviral drug Obeldesivir is underway in the Democratic Republic of the Congo to investigate whether it can “prevent illness in people who have experienced high-risk exposure to Bundibugyo Ebolavirus”.

For ‘public health experts’, these rapid pace development blueprints signal a shift towards preparing vaccines before they ‘trigger larger epidemics’, rather than developing them only after ‘outbreaks’ are already underway – which has been the traditional method in science.

They also want jabs moving forward to hit the marketplace at quicker speeds than previous generations of vaccines, fast-tracked through clinical testing frameworks like during COVID.

Ebola has always been a key step in this evolution of world health responses.

RAPID RESPONSE ERA

Ebola is a topic that has continuously advanced vaccine manufacturing capabilities and the regulatory rules of many countries, initially forming the basis of how we responded to the ‘pandemic’ era under the guise of ‘biosecurity preparedness’.

Now it has ‘returned’ again to continue that pattern.

In May, the World Health Organization issued its highest international health alert over the latest ‘outbreak’ in Central Africa, citing “…growing concerns about cross-border transmission and limited vaccine protection”.

WHO declares latest Ebola outbreak a ‘global health emergency’
RELATED ARTICLE

This is not the first time WHO has invoked its highest emergency alert for Ebola.

In 2014, the organisation declared a similar emergency during the West African ‘epidemic’ that affected Guinea, Liberia, and Sierra Leone.

That outbreak became the ‘largest Ebola epidemic in recorded history’, reportedly killing more than 11,000 people and ‘overwhelming healthcare systems’ across the region.

In 2014, Bill Gates pledged over $50 million for ‘emergency operations and research’ relating to the Ebola outbreak – raising many suspicions with anyone following his work at the time.

It was during this time that controversial ‘biosecurity’ laws were passed in Australia that would eventually underpin COVID-19 restrictions just half a decade later.

New Australian law allows forced quarantine to ‘prevent suspected disease’
RELATED ARTICLE

We warned at that time that genomic surveillance of society, coupled with authoritarian quarantine powers, could potentially be the next move of the global elitist parasites.

WHO again declared an international emergency in 2019 after another ‘major outbreak’ in the Democratic Republic of the Congo, fearing it would spread into neighbouring countries.

Each time, a new layer is added onto research capabilities and contingency plans of nations.

It seems like this time, the new ‘strain’ is the perfect test of rapid response training largely mastered with rushed jabs that emerged during COVID.

They have already been practicing for the next ‘outbreak’ to emerge since then.

Last year, the University of Queensland was in a race to create a new vaccine in just 150 days, as part of a ‘future pandemic pressure test’ set by CEPI themselves.

University of Queensland testing vaccine development response time
RELATED ARTICLE

The 100 Days Mission challenge – set by the Gates-funded CEPI – was “…a real-time test to see how fast science can respond to emerging viral threats”.

Now we see CEPI behind fast-tracking these new Ebola vaccines?

What is going on here?

Is this a test for something larger to come?

There has been suspicion ever since the COVID era ended and ‘Disease X’ propaganda emerged that a new manufactured ‘infectious disease’ narrative is in the pipeline.

Take your pick – tick allergies, bird flu, diphtheria, etc.

The disease merry-go-round is in motion here in Australia.

Only solved by fast-tracked next-generation vaccines, and only prevented from happening again with annual top ups of these jabs directly into your arm.

How long before the biological experiment fields of Africa and other third-world locations are expanded to the larger planet again?